Tag: acute respiratory distress syndrome

January 23, 2019

Athersys Announces Positive Results From Its Exploratory Clinical Study of MultiStem Cell Therapy

Athersys (NASDAQ:ATHX) announced summary results from its exploratory clinical study of the intravenous administration of MultiStem® cell therapy to treat...
June 7, 2018

Athersys Announces Expansion of Collaboration With Healios

Athersys (NASDAQ:ATHX) announced today that it has entered into an agreement with HEALIOS K.K. to expand their collaboration into additional...
January 29, 2018

Faron Pharmaceuticals: FDA grants Fast Track Designation to Faron for Traumakine®

Faron Pharmaceuticals (AIM: FARN), the clinical stage biopharmaceutical company, announces it has received Fast Track designation from the US Food...
January 24, 2018

FDA has approved Faron's Traumakine® IND

Faron Pharmaceuticals (AIM: FARN) a clinical stage biopharmaceutical company, announced the US Food and Drug Administration has approved the Investigational...
May 8, 2017

Prometic To Present New Findings on Acute Lung Injury

Prometic Life Sciences will present new data on the benefits of plasminogen administration to reduce lung injury in animal model...